Linezolid resistance in clinical isolates of Staphylococcus aureus

被引：238

作者：

Wilson, P ^{[1
]}

Andrews, JA

Charlesworth, R

Walesby, R

Singer, M

Farrell, DJ

Robbins, M

机构：

[1] UCL Hosp, Dept Clin Microbiol, London, England

[2] Royal Free & Univ Coll Med Sch, Bloomsbury Inst Intens Care, London, England

[3] GR Micro Ltd, London, England

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2003年 / 51卷 / 01期

关键词：

oxazolidinone; resistance; Staphylococcus aureus; linezolid;

D O I：

10.1093/jac/dkg104

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：186 / 187

页数：2

共 5 条

[1] BSAC standardized disc susceptibility testing method [J].

Andrews, JM .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 :43-57

[2]

[Anonymous], 38 SAN DIEG CA US IN

[3]

Howe RA, 2002, 42 INT C ANT AG CHEM, P75

[4] Linezolid - A review of its use in the management of serious Gram-positive infections [J].

Perry, CM ;

Jarvis, B .

DRUGS, 2001, 61 (04) :525-551

[5] Linezolid resistance in a clinical isolate of Staphylococcus aureus [J].

Tsiodras, S ;

Gold, HS ;

Sakoulas, G ;

Eliopoulos, GM ;

Wennersten, C ;

Venkataraman, L ;

Moellering, RC ;

Ferraro, MJ .

LANCET, 2001, 358 (9277) :207-208

← 1 →